Improving recovery after pancreatic surgery
Official title: Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy; Experience From Two Referral Centers in Central Greece.
Run by University of Thessaly · NCT06935448 · Data updated 2026-11-12
This study is testing if a special recovery program can help people recover better and faster after surgery for pancreatic cancer compared to standard care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | University of Thessaly Academic / other |
| Locations | 1 site (Larissa) |
| Status | Recruiting |
| Started | July 1, 2019 |
| Main results expected | April 30, 2025 |
| Study ends | May 30, 2025 |
| Registry record updated | April 20, 2025 |
| Trial ID | NCT06935448 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients diagnosed with resectable pancreatic cancer who are scheduled for elective open pancreatic surgery.
✕Probably not a fit
Patients who are under 18 years old, require emergency surgery, or have incomplete data will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the impact of an Enhanced Recovery After Surgery (ERAS) program on patients undergoing pancreatoduodenectomy for pancreatic cancer. Conducted at two high-volume referral centers in Greece, the study compares outcomes of patients managed under a standardized ERAS protocol to a control group that received standard care. Key outcomes measured include length of hospital stay, as well as 30-day mortality and morbidity rates, to assess the effectiveness of the ERAS approach in enhancing postoperative recovery.
Why it matters
Potential benefit: If successful, this program could lead to shorter hospital stays and improved recovery for patients undergoing surgery for pancreatic cancer.
How similar studies have gone: Previous studies have shown that ERAS protocols can significantly improve surgical outcomes, suggesting a promising approach in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients * diagnosis of pancreatic cancer * elective open pancreatic surgery Exclusion Criteria: * age \<18 years * emergency pancreatic surgery * other surgical procedures * missing data * lost to follow-up
Where it's running
-
University of Thessaly
Larissa, Greece Recruiting
Study contacts
- Principal investigator: DESPOINA LIOTIRI, MD, DESAIC, EDRA, MSc, PhD(c) — University of Thessaly
- Study coordinator: DESPOINA LIOTIRI, MD MSc PhD(c)
- Email: deppieliotiri@gmail.com
- Phone: 00302410996000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tramadol vs Morphine for Postoperative Pain After Laparoscopic Abdominal Surgery
This study tests whether tramadol can provide comparable pain relief to morphine after laparoscopic abdominal surgery when used as part of multimodal pain management.
-
Pancreatic Surgery and New Diabetes Risk in Adults without Diabetes
This study tests whether removing part or all of the pancreas during surgery affects blood sugar control and metabolism in adults who did not have diabetes before the operation.
-
PancreasPlus app for monitoring recovery, symptoms, and education after pancreatic cancer treatment
This project will test whether the PancreasPlus app helps adults with pancreatic cancer and their caregivers monitor symptoms, get timely information, and communicate with their healthcare team.
-
Chronic Stress and Pancreatic Cancer Outcomes in People with Pancreatic Cancer
This study tests whether ongoing psychological stress affects how pancreatic cancer behaves and responds to treatment in adults.
-
Hybrid Closed-Loop Insulin Delivery After Pancreatectomy
This study tests whether a commercially available monohormonal hybrid closed-loop insulin delivery system can help adults who developed diabetes after pancreatectomy better manage blood sugar.
-
Neoadjuvant chemotherapy versus immediate surgery for resectable pancreatic head and periampullary cancer
This trial tests if giving chemotherapy before surgery helps people with resectable pancreatic head or periampullary cancer live longer than having immediate surgery followed by chemotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.